Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy
about
CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pancreatic carcinoma mouse model.Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationCharacterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancerAnimal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics.LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.There are four dynamically and functionally distinct populations of E-cadherin in cell junctions.Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic CancerLoss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer.Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development.Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar to Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.
P2860
Q30358993-C0282733-480D-4E56-A9F0-BC3F557FE2BBQ33703133-6E94431F-E518-48A3-878F-1F32BFBC5D17Q34790492-40C610BB-6FFE-4611-9791-25E7BEF9F84DQ35678372-D9BFEFE0-7991-4CBB-B8F3-C1FAFDDE00D3Q36001882-C5AB7DF1-B9E9-4729-89BB-5F31755B0820Q36017810-1C20AB99-4ABE-4B2E-8B50-9CF102DFFD98Q36364191-A3173ADB-5F15-4D71-8A01-B0830A5C48A3Q36506709-A643C3AA-DBB4-4DA6-8467-F8948D1220B8Q36772125-E268E84A-0FD8-4B8B-8B50-874BA67905A5Q36852611-563EB726-F06B-4247-B84A-CD630659B22FQ37174016-C2754B3B-CC0A-4F04-9D95-A65D33A0ACCBQ37247525-2AA33101-B9F1-4BA1-AA1A-9B3C6AEE5E57Q37500149-C9B08E4A-2CA4-48AD-8E99-AC8F4AA8055BQ37660216-EEA9C6F5-7F3A-4CD0-A822-C42CF65BEDAAQ38695950-131744AB-73BA-4061-A092-571226C52157Q38718943-0FDD0BF3-234A-47C2-A69D-22B281BCCBDCQ38908575-8BD69F43-FABC-49C3-8403-1F8DFE613FECQ38935085-D5043E34-5E1A-40E0-9DE2-86580BCA9EFCQ42290164-84FC7278-699A-4637-BA09-A2E017614A14Q46014755-328951F4-00F8-42D3-AB33-D3AB0571A0C8Q47155954-25E85969-847B-4B79-BFD7-6CD7761CBA6DQ47217912-E01C9439-771A-4727-B020-73E67F7398CEQ49722539-D7E20DBC-962F-4AA7-983F-08EEC5AC5BFBQ50544084-B90B8625-FB36-463A-8223-AB4D6579C921
P2860
Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@ast
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@en
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@nl
type
label
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@ast
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@en
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@nl
prefLabel
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@ast
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@en
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@nl
P2093
P2860
P4510
P1433
P1476
Novel pancreatic cancer cell l ...... tions in diagnosis and therapy
@en
P2093
Kavita Mallya
María P Torres
Satyanarayana Rachagani
Sonny L Johansson
Surinder K Batra
P2860
P304
P356
10.1371/JOURNAL.PONE.0080580
P407
P577
2013-01-01T00:00:00Z